Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Shawn Singh | M | 61 |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions.
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | 24 years |
Jon Saxe | M | 88 |
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID.
VistaGen, Inc.
| 24 years |
Ann Cunningham | F | 56 | 5 years | |
Mark Flather | M | - | 3 years | |
Mary Rotunno | F | 64 | 3 years | |
Joanne Curley | M | 56 | 3 years | |
Mark McPartland | M | 58 | 8 years | |
Jerry Gin | M | 81 | 8 years | |
Maggie FitzPatrick | F | 58 | 3 years | |
Alex Bardi | M | - |
VistaGen, Inc.
| 25 years |
Louis Monti | M | - | 4 years | |
Mark Ginski | M | - | 3 years | |
Reid Adler | M | 70 | 2 years | |
Erik Berglund | M | - | 3 years | |
Ross Baker | M | - | 3 years | |
Trisha Fitzmaurice | F | - | 2 years | |
Joshua Prince | M | 54 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
A. Franklin Rice | M | 70 |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions.
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | 12 years |
Matthew L. Jones | M | 55 |
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | - |
Brian Underdown | M | 83 |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions.
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | 12 years |
Gregory Bonfiglio | M | 72 |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions.
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | 6 years |
Stephanie Y. Jones | F | 50 |
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | - |
Jerrold Dotson | M | 71 | 12 years | |
Glenn L. Cooper | M | 71 |
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | 2 years |
Lawrence K. Cohen | M | 70 |
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | 1 years |
Stephen J. Williams | M | - |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | - |
Allen Cato | M | - |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | - |
Mark A. Smith | M | 68 | 6 years | |
Gordon M. Keller | M | - | - | |
Ellis Wilson | M | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 30 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- H. Ralph Snodgrass
- Personal Network